Growth Metrics

Volitionrx (VNRX) Gross Margin (2020 - 2025)

Volitionrx (VNRX) has disclosed Gross Margin for 7 consecutive years, with 126.66% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Margin fell 463.0% year-over-year to 126.66%, compared with a TTM value of 277.18% through Sep 2025, up 9035.0%, and an annual FY2024 reading of 334.89%, up 44775.0% over the prior year.
  • Gross Margin was 126.66% for Q3 2025 at Volitionrx, up from 326.09% in the prior quarter.
  • Across five years, Gross Margin topped out at 122.03% in Q3 2024 and bottomed at 14804.78% in Q4 2021.
  • Average Gross Margin over 5 years is 2053.68%, with a median of 875.18% recorded in 2024.
  • Peak annual rise in Gross Margin hit 4868508bps in 2021, while the deepest fall reached -1014336bps in 2021.
  • Year by year, Gross Margin stood at 14804.78% in 2021, then surged by 91bps to 1301.87% in 2022, then surged by 48bps to 678.32% in 2023, then rose by 18bps to 553.09% in 2024, then soared by 77bps to 126.66% in 2025.
  • Business Quant data shows Gross Margin for VNRX at 126.66% in Q3 2025, 326.09% in Q2 2025, and 272.3% in Q1 2025.